Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Jachs

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2026
Stage-specific drivers of clinical progression in advanced chronic liver diseaseBenedikt Simbrunner, Georg Semmler, Marta Bofill Roig, et al.
Journal of Hepatology|October 25, 2025
Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysisJuan Bañares, Mònica Pons, Thomas Reiberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 18, 2024
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International NetworkAnika Wranke, Cirley Lobato, Emanoil Ceausu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2021
Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patientsCaroline Schmidbauer, David Chromy, Victor U Schmidbauer, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis DLisa Sandmann, Mathias Jachs, Tammo L Tergast, et al.
Scientific Reports|July 30, 2024
Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective studyLarissa Nixdorf, Lukas Hartl, Stefanie Ströhl, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 7, 2025
UDFF and Auto pSWE accurately assess liver steatosis and fibrosis risk in obese patients with MASLDNina Dominik, Larissa Nixdorf, Michael Schwarz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2026
Post-TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS PlacementMarlene Hintersteininger, Simon Johannes Gairing, Katrin Kirsch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 4, 2025
The Vasopressin Biomarker Copeptin is Linked to Systemic Inflammation and Refines Prognostication in Decompensated CirrhosisLukas Hartl, Marlene Hintersteininger, Benedikt Simbrunner, et al.
Hepatology (Baltimore, Md.)|March 6, 2024
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertensionGeorg Semmler, Lukas Hartl, Yuly Paulin Mendoza, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2026
Stage-specific drivers of clinical progression in advanced chronic liver diseaseBenedikt Simbrunner, Georg Semmler, Marta Bofill Roig, et al.
Journal of Hepatology|October 25, 2025
Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysisJuan Bañares, Mònica Pons, Thomas Reiberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 18, 2024
Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International NetworkAnika Wranke, Cirley Lobato, Emanoil Ceausu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 16, 2021
Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patientsCaroline Schmidbauer, David Chromy, Victor U Schmidbauer, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis DLisa Sandmann, Mathias Jachs, Tammo L Tergast, et al.
Scientific Reports|July 30, 2024
Rapid improvement of hepatic steatosis and liver stiffness after metabolic/bariatric surgery: a prospective studyLarissa Nixdorf, Lukas Hartl, Stefanie Ströhl, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 7, 2025
UDFF and Auto pSWE accurately assess liver steatosis and fibrosis risk in obese patients with MASLDNina Dominik, Larissa Nixdorf, Michael Schwarz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 9, 2026
Post-TIPS Dynamics of von Willebrand Factor for Risk Stratification After TIPS PlacementMarlene Hintersteininger, Simon Johannes Gairing, Katrin Kirsch, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 4, 2025
The Vasopressin Biomarker Copeptin is Linked to Systemic Inflammation and Refines Prognostication in Decompensated CirrhosisLukas Hartl, Marlene Hintersteininger, Benedikt Simbrunner, et al.
Hepatology (Baltimore, Md.)|March 6, 2024
Simple blood tests to diagnose compensated advanced chronic liver disease and stratify the risk of clinically significant portal hypertensionGeorg Semmler, Lukas Hartl, Yuly Paulin Mendoza, et al.
Pageof 12